Introduction There is a lack of consensus about the defi nition of fl are of rheumatoid arthritis (RA) and a measurement tool. Objectives To develop a self-administered tool integrating the perspectives of the patient and the rheumatologist, enabling the detection of present or recent-past RA fl are. Methods The patient perspective was explored by semistructured individual interviews of patients with RA. Two health psychologists conducted a content analysis to extract items best describing fl are from the interviews. The physician's perspective was explored through a Delphi exercise conducted among a panel of 13 rheumatologists. A comprehensive list of items produced in the fi rst round was reduced in a four-round Delphi process to select items cited by at least 75% of the respondents. The identifi ed elements were assembled in domains-each converted into a statement-to constitute the fi nal self-administered Flare Assessment in Rheumatoid Arthritis (FLARE) questionnaire. Results The content of 99 patient interviews was analysed, and 10 domains were identifi ed: joint swelling or pain, night pain, fatigue and different emotional consequences, as well as analgesic intake. The Delphi process for physicians identifi ed eight domains related to objective RA symptoms and drug intake, of which only four were common to domains for patients. Finally, 13 domains were retained in the FLARE questionnaire, formulated as 13 statements with a Likert-scale response modality of six answers ranging from 'absolutely true' to 'completely untrue'. Conclusion Two different methods, for patient and physician perspectives, were used to develop the FLARE self-administered questionnaire, which can identify past or present RA fl are. JMB and MDB contributed equally to this study.
INTRODUCTION
Although the question of a consensual defi nition of rheumatoid arthritis (RA) fl are has been raised previously, [1] [2] [3] [4] clinicians still lack a consensual definition for it, from either a conceptual or practical point of view. [1] [2] [3] [4] This lack of consensus is due in part to the ambiguity of the concept because of two possible approaches to the defi nition.
The fi rst approach may represent an ongoing worsening in RA activity of suffi cient duration to prompt a change in RA treatment. This approach has been preferred by the Outcome Measures in Rheumatology (OMERACT) Flare group, which sought mainly to describe clinically relevant worsening, fi rst in randomised controlled trials (RCTs) incorporating the patient's perspective, to improve the ability to capture loss of effi cacy as early as possible in RCTs and longitudinal observational and post-marketing studies, 5 and ultimately in clinical practice. 6 In a preliminary defi nition, fl are was accordingly defi ned as 'a cluster of symptoms of suffi cient duration and intensity that cannot be self-managed by the patient and require initiation, change or increase in therapy'. 2 5 7 In this approach, fl are is the opposite of improvement, keeping in mind that the intensity of change is not symmetrical between the two notions.
In the context of RCTs, visits are already scheduled and separated by quite short intervals, allowing adaptation of the treatment as soon as a signifi cant 'fl are' is prospectively detected. This defi nition of fl are does not yet consider the possibility of transient exacerbation of disease activity with spontaneous return to baseline disease activity.
The second approach encompasses any disease exacerbation, either transient (ie, spontaneously regressive) or long lasting. Such a defi nition would be more suitable for all settings, either in clinical research or daily practice, for identifying present fl are or exacerbation of RA activity that has occurred between two visits to the physician. Transient fl ares defi nitely occur during RA, and may have signifi cant impact on disease outcome. Welsing et al showed that brief and marked fl uctuations in disease activity in patients with apparently stable RA are directly related to radiographic evidence of disease progression, which suggests that, at the individual level, transient fl uctuations can also induce variation in structural damage. 8 This evidence may explain structural damage progression in patients with apparent remission at successive medical visits. Because fl uctuations in disease activity are common in chronic infl ammatory rheumatisms, 9 there is defi nitely an unmet ▶ Additional data are published online only. To view these fi les, please visit the journal online (http://ard.bmj.com/ content/71/7.toc).
For numbered affi liations see end of article
In the fi rst step, the two health psychologists performed an explanatory thematic analysis based on a non-structured discussion with 10 patients, who were asked to describe their usual symptoms and feelings when a disease fl are occurs, and 26 themes were initially developed. The eight most frequently reported were fi nally selected to develop the format of subsequent patient interviews. In the second step, this guide of eight main themes with open questions was an opportunity for 102 other patients to offer their opinions on fl are. Over 350 pages, the patients described in detail what they experienced during an RA fl are. Codes were developed for latent characteristics that can be reliably applied, and a coding frame was created that contains the label for each code, its defi nition, and examples of what should and should not be coded with it. To establish the reliability of the coding system, two people then independently used the manual to apply the codes. Finally, the identifi ed attributes were reorganised into discrete domains, each representing a relevant RA fl are feature.
Physician perspective
A panel of 13 senior university rheumatologists (all listed among the authors) experienced in the care of patients with RA participated in a Delphi exercise. The rheumatologists were fi rst asked to list the elements that best refl ected RA fl ares, introduced as transient exacerbations of disease activity. They were asked to respond to the following statement: 'By excluding the variations of disease activity due to an end-ofdose effect from a treatment such as biotherapy, please state the elements that you consider to best describe or represent a fl are in an RA patient'. Each expert had to propose at least 10 items during the preliminary round. The proposed items were fi rst organised into several domains and then reduced during a four-round Delphi process in which items were defi nitively selected when cited by at least 75% of the 13 participants and defi nitively rejected when cited by fewer than 25% of them. At each round, the remaining items were maintained for the following procedure.
Elaboration of self-administered questionnaire and cognitive testing
Both patient-and physician-reported domains were used to develop the Flare Assessment in Rheumatoid Arthritis (FLARE) self-administered questionnaire. During the fi nal meeting between the senior rheumatologists and the health psychologists in charge of the interview analysis, all domains were collected, and an affi rmative statement was formulated for each domain. This format was preferred over an interrogative one, because the latter is usually perceived as intrusive by patients. The response modality was a Likert scale of six answers ranging from 'absolutely true' to 'completely untrue'.
A complementary study was performed in April 2011 on a series of 12 new patients with RA (different from those who were involved in the previous interviews), who were asked fi rst to read the questionnaire. These 12 patients were asked whether they felt that this questionnaire described a fl are, 'their' fl are, and did not miss any important features of RA fl are. They were also asked to read each item separately, and comment on it, by responding to four questions. (1) Is the item suggestive of a fl are? (2) Does the wording need improvement? (3) Would you suggest changes in terms? (4) Which item do you feel to be the most important for describing a fl are of RA?
need to identify such transient fl ares because they would be predictive of future worse outcome and would justify treatment adaptation even in patients in stable remission at the time of the consultation.
Defi ning RA fl are raises another complex issue related to the difference in perception or concept of fl are between patients and health professionals. Physicians may focus more on objective signs, such as the clinical features observed during the medical visit, but fail to notice patient-reported events that occurred before the consultation. Patients may have a different concept, depending fi rst on what they experience in daily life as a consequence of the disease and its activity. For instance, a previous study on fl are in ankylosing spondylitis showed that, besides acute pain, many patients experienced reduced mobility, fatigue, depression, anger, fear and generalised whole-body reactions felt as a devastating phenomenon. 10 Moreover, patients may disagree with physicians on the magnitude of disease activity worsening required to defi ne a fl are. Indeed, in a study by Leeb et al, in contrast with physicians' perspectives, patients required greater improvement to feel satisfi ed, and less worsening to feel dissatisfi ed. 11 Defi ning a worsening of RA should clearly not depend on only physicians' perspectives. 12 The Strategy of Treatment in Patients with Rheumatoid Arthritis (STPR) initiative, comprising a group of senior faculty rheumatologists, [13] [14] [15] began a study in 2007 with the goal of developing a self-administered tool to capture RA fl are according to the second approach described above: transient or long lasting, present or recent (ie, within the previous 3 months to limit recall bias), regardless of any clinical evaluation by the rheumatologist. In this work, we aimed, through creation of a questionnaire, to defi ne the components constituting RA fl are according to patient and physician perspectives, and to develop the domains able to identify and capture such a fl are.
METHODS
The study involved developing two comprehensive lists of items that could defi ne fl are from a patient and/or a rheumatologist perspective with two qualitative methods: semistructured interviews to elicit patient views, and a Delphi exercise to reach consensus among physicians.
Patient perspective
Before the study, two health psychologists (FB, ES) performed a content analysis based on a non-structured discussion with 10 patients with RA and used their answers to develop the format of subsequent patient interviews that were planned in the main study (see online supplementary text).
Then, eight to ten consecutive patients with established RA (ie, more than 2 years' duration) included in each of the 13 participating rheumatology departments were asked to participate in individual semistructured interviews that explored their feelings and thoughts about RA fl are. A research nurse or a health psychologist in each centre conducted 10-15 min interviews, which were recorded for further analysis. All patients received adequate information about the objectives and process of the study and gave their consent to participate before the interview.
Content analysis
The interviews were transcribed on to paper by the two health psychologists (FB, ES), and their content was analysed to identify the attributes patients used to describe RA fl are and the frequency with which these elements were cited.
All the remaining domains were used to build the questionnaire. For each domain, the group of physicians and health psychologists developed a statement presenting the concept of the domain. The statements were homogeneously formulated and introduced as follows: 'In the last 3 months, or at some time since the last medical consultation, < statement >'. For each statement, the respondent had to indicate agreement by choosing on a Likert scale one of six possible answers from 'absolutely true' to 'completely untrue'. The English version of the FLARE self-reported questionnaire is presented in table 2, and the original French version in table 3.
Responses to the complementary study
The hierarchy of responses for the question 'which item do you feel to be one of the most important for describing a fl are of RA' was: item 5 (7/12 patients selected it as 'one of the most important'), items 3, 4, 8, 9, 10, 11, 12 (selected by 6/12 patients), items 1, 13 (selected by 5/12 patients), items 2, 6 (selected by 4/12 patients), and item 7 (selected by 3/12 patients). In other words, items 8-13 (selected only by the fi rst set of 102 patients) were as often considered as 'the most important' in this complementary study as items 1-7 (selected only by the physicians).
DISCUSSION
We developed a self-administered tool that aims to detect RA fl ares between two medical consultations. The FLARE questionnaire should be appropriate for identifying any increase in RA disease activity regardless of its duration (transient or long lasting). However, this tool still needs to be validated, and its ability to ensure a tighter adjustment of treatments to the overall activity of RA between two visits will also need further assessment. In its fi nal version, it should be suitable for clinical research and might be for daily clinical practice.
The concept of fl are usually differs according to patient and physician perspectives. Patients focus on subjective changes such as pain, general signs, mood disturbance and the need to seek help. 5 Physicians are more likely to consider objective changes on which they can base treatment decision-making.
RESULTS

Patient perspective
In total, 102 patients were interviewed, and complete data were available for 99. Most patients (61%) reported that a fl are usually starts with a feeling of swelling in the joints, and 11% mentioned frozen joints. An increase in pain was cited by all patients, with various qualifi cations of pain (very strong, 54%; arduous, 7.1%; shooting, 16.1%; unbearable, 19.6%; excruciating, 7.1%) and associated with an increase in daily intake of analgesics (eg, non-steroid anti-infl ammatory drugs, steroids) for 82% of patients. During the fl are, 66.6% of patients declared feeling depressed, 77% having sleep disturbances, 91% feeling more tired, and 96% reporting repercussions on daily activities. Patients reported feeling loss of independence (87.5%) and emotionally more fragile during the fl are (91%). Only 9% of the participants reported fl u-like symptoms.
From this content analysis, we selected 10 domains to describe RA fl are according to the patient perspective. Six answer modalities were proposed for these 10 items, which allowed detection of items over the preceding 3 months (table 1) .
Physician perspective
In the fi rst Delphi round, the rheumatologists proposed 105 items, which were homogenised to 19 items and organised into 14 domains, then used for subsequent rounds. The Delphi process required four additional rounds to obtain converging results in which all domains were accepted by more than 75% of the respondents. Finally, eight domains were selected, one biological and seven clinical.
Development of the FLARE self-administered questionnaire
Among the 10 patient-reported domains and the eight physician-reported ones, four were the same: joint swelling, pain, sleep disturbance and intake of analgesics. During the fi nal meeting, the common domains were merged. A domain relative to biological work-up abnormalities-mentioned by the physicians-was eliminated because it did not fi t with the framing of a self-administered questionnaire. 38 Physician global assessment 38 Feeling of an arthritic fl are 'Non-selected items' refer to items not selected during the last round of the Delphi process in the list devoted to the rheumatologists' perspective, as fewer than 75% of rheumatologists accepted them in this round (62%, 46%, 38%). Conversely, all attributes identifi ed during the analysis of the semistructured interviews were kept in the patient's list.
group.bmj.com on April 5, 2018 -Published by http://ard.bmj.com/ Downloaded from Table 2 The FLARE self-administered questionnaire Information before scale completion: this questionnaire has been designed to be completed by the patient him/herself or by the physician asking the questions during a consultation In the last 3 months (or at some time since the last consultation) please indicate how true the statements below are for you personally (please tick the number) group.bmj.com on April 5, 2018 -Published by http://ard.bmj.com/ Downloaded from a Likert scale with six possible answers for each question, which offers the opportunity to express the fi nal result of the 'fl are instrument' quantitatively (as a score) or qualitatively (fl are or no fl are, according to a threshold for fl are). This format has still to be defi ned and tested against an anchor assessment of RA activity by another score with previously established thresholds of signifi cance, such as routine assessment of patient index data (RAPID)-3, which can be longitudinally fulfi lled by the patients on a home-made basis. 25 Second, the duration of symptom exacerbation remains to be clarifi ed. Our patient interviews revealed signifi cant variations in the defi ned duration of fl are, ranging from a few days to a couple of weeks or months. These discrepancies have been observed in other diseases. 10 19 21 The scientifi c community has identifi ed an area for research, because defi nition of a 'suffi cient duration' (to lead to structural damage) may be as important as the defi nition of fl are itself. While waiting for such a defi nition, we chose to capture any fl are the patient remembered, regardless of its duration or recurrence.
The third issue relates to the ability of patients to correctly remember with suffi cient accuracy all events occurring between two clinic visits. We chose a period of 3 months because it is the delay most often considered optimal in RA care. A longer period could be subjected to a stronger memory bias. Indeed, previous studies have shown that retrospective evaluation of pain within the past week or month already leads to a slight overestimation of pain actually experienced during those short periods. 26 27 However, patients with RA seemed to more correctly recall and report fl are frequency and pain intensity than other painful conditions. 26 28-30 However, problems could arise with features other than pain, especially general features (fl u-like symptoms), which are probably forgotten even more quickly than worsening of pain. This situation may be illustrated by only a few of our patients focusing on this aspect, although it has been emphasised in group meetings of patients. 5 10 The fourth limitation (inherent to the choice of a self-administered tool also allowing the detection of fl ares between two visits) was the need to discard both biological results and physicians' global assessment from the list of items fi rst selected by physicians during the Delphi process.
The fi fth issue is that this questionnaire has only been developed in the French language, with the input of French physicians and patients. Trans-cultural differences in the meaning of 'fl are' might have led to the selection of different items or wordings in other languages or settings.
Last, whether the patients perceive the questions as only related to their arthritis/condition, or as a result of other outside forces, has not been tested.
This tool needs to be validated in a prospective trial of patients with three main objectives: (1) the validity of the tool 31 (internal validity, measured with a multiple factorial analysis, and a Rasch model, the external validity being evaluated by correlation scores with the RAPID and the rheumatoid arthritis impact of disease score); (2) the reliability and responsiveness of the tool (reproducibility, sensitivity to change, and effect of the tool on decision) 31 ; and (3) the feasibility of using this score, 31 even in daily practice. Then, the predictive capacity of the tool must be evaluated.
Different scientifi c organisations such as the OMERACT group, the American College of Rheumatology or the European League Against Rheumatism have recommended considering both perspectives because they are usually not redundant, 16 17 but often complement each other. This recommendation was confi rmed in our work because only four of the 10 patient-proposed items and eight physician-proposed items were common to both types of respondent: joint swelling, pain, sleep disturbance and intake of analgesics.
The FLARE self-administered questionnaire is also complementary to the rheumatologist examination (eg, joint counts or disease activity score using 28 joint counts) because it collects information about disease activity that occurred between two consultations and may be absent at the time of the visit to the physician.
The FLARE instrument may also be useful for patients to selfdetect a fl are and subsequently ask for a prompt appointment, although thresholds could vary according to the patient. Indeed, Hewlett et al 18 showed in a 6-year prospective trial that patients with RA who initiated their reviews through direct access were clinically and psychologically at least as well as patients with traditional reviews initiated by physicians. Moreover, the former patients requested fewer appointments (more than onethird fewer medical appointments), which reduced the overall use of restricted healthcare resources. 18 Many chronic diseases can be punctuated by exacerbations. These exacerbations are not always captured by activity scores, which are obtained only during scheduled visits and require physician assessment and/or blood sampling (erythrocyte sedimentation rate or C-reactive protein measurement). Fluctuations of suffi cient duration could affect radiographic and functional outcome. 8 'Flare' is commonly used by patients and clinicians to describe a worsening of symptoms and is encountered in various autoimmune diseases such as atopic dermatitis, 19 ankylosing spondylitis, 9 juvenile arthritis, 20 21 lupus 22 23 and gout. 24 Numerous efforts have aimed to defi ne validated end points for improvement in RA in RCTs or in daily practice, but no thresholds have been set to defi ne a signifi cant worsening of disease activity. 5 Accordingly, although 'RA fl are' is conceptually recognised, evidence is limited and a consensual defi nition is lacking. 5 7 This absence is not restricted to RA, because a defi nition of gout fl are has not yet been validated, even though gout has been described since antiquity 24 and experienced by millions of patients; nevertheless, patients are treated and cured.
The OMERACT group defi ned fl are in RA as 'a cluster of symptoms of suffi cient duration and intensity that cannot be self-managed by the patient and require initiation, change or increase in therapy'. 5 7 This defi nition does not explicitly consider the possibility of a return to disease baseline ('end of fl are'), because the authors sought to build a tool for RCTs fi rst (to recognise as soon as possible loss of effi cacy of treatments or quantitatively characterise reasons for study withdrawal on the basis of loss, or lack, of effi cacy), 5 although the ultimate goal is also to enhance clinical care. 6 Our work seems to be complementary to the OMERACT initiative, which involves some of the STPR members. Although based on a slightly different concept of fl are and different methodology, the preliminary results of the OMERACT project and our results are consistent.
At least six issues remain unresolved. First, no threshold of disease worsening has been established to defi ne a fl are, which may be explained by the perception of the severity of fl are differing between patients, and for a single patient from time to time. This variation in severity of fl are prompted us to propose
